https://www.scientificamerican.com/article/whats-holding-up-new-omicron-vaccines1/
In public statements, Pfizer claimed it could deliver an Omicron-based vaccine by March 2022 “if needed.” But the company has not committed to beginning the necessary large-scale effectiveness trials.
